Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075.
MAGNESIUM SULFATE vs SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Sodium chloride and potassium chloride are electrolytes that maintain osmotic balance, fluid distribution, and proper cellular function. Sodium is the primary extracellular cation involved in fluid balance, nerve impulse transmission, and muscle contraction. Potassium is the major intracellular cation essential for cardiac, skeletal, and smooth muscle activity, and acid-base balance.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Intravenous infusion; typical adult dose is 1-2 mL/kg/hr adjusted based on serum electrolyte levels and fluid status. For maintenance, 30 mL/kg/day of 0.9% sodium chloride with 0.075% potassium chloride (KCl 10 mEq/L) at a rate of 100-125 mL/hr. Not to exceed 20 mEq KCl per hour.
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateNone Documented
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Sodium and potassium have no true terminal half-life as they are homeostatically regulated. In steady-state, sodium turnover half-life is approximately 2-3 weeks, while potassium has a faster turnover of about 40 hours in skeletal muscle. Clinically, redistribution after IV infusion occurs within hours, with renal excretion adapting rapidly.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Sodium and potassium ions are primarily excreted renally. Sodium elimination follows glomerular filtration with 99% tubular reabsorption, while potassium is filtered, then 90% is reabsorbed in proximal tubule and loop of Henle, with distal secretion regulated by aldosterone. Fecal excretion is minimal (<5%) under normal conditions.
Category C
Category A/B
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."